Canadian Sec - Delayed Quote CAD

Sona Nanotech Inc. (SONA.CN)

0.3250
+0.0150
+(4.84%)
At close: May 12 at 3:39:48 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. David Andrew Regan Chief Executive Officer 260k -- 1969
Mr. Robert William George Randall CPA CFO & Corporate Secretary 66.28k -- 1963
Dr. Len Pagliaro Ph.D. CSO & Director 174.59k -- --
Dr. Carman Giacomantonio M.D., M.Sc. Chief Medical Officer 57.5k -- --
Dr. Kulbir Singh Ph.D. Co-Founder & Head of R&D -- -- --
Dr. Mike McAlduff Director of R&D & Production and Founder -- -- --
Dr. Gerrard Marangoni Co-Founder & Member of Scientific Advisory Board -- -- --
Mr. Darren Rowles Head of Diagnostics 189k -- 1980

Sona Nanotech Inc.

Purdy’s Wharf Tower II
Suite 2001 1969 Upper Water Street
Halifax, NS B3J 3R7
Canada
902 442 0653 https://www.sonanano.com
Sector: 
Healthcare

Description

Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.

Corporate Governance

Sona Nanotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 27, 2025 at 8:00 PM UTC - July 1, 2025 at 8:00 PM UTC

Sona Nanotech Inc. Earnings Date

Recent Events